Aetna reported better-than-expected adjusted earnings in its first quarter, helped primarily by strength in the U.S. health insurer's commercial and government unit even as it continued to face pressure in its Obamacare business. It reported a loss of $1.11 per share, The company reported a quarterly loss primarily due to costs associated with the termination of the Humana merger agreement.On May 19, 2017, the board of directors for Aetna declared a quarterly cash dividend of $0.50 per share on the company’s common stock, which was distributed on July 28th 2017. The powerful  first quarter performance demonstrated the power of the disciplined execution of Aetna’s strategy, enabling Aetna to absorb continued pressure from our individual commercial products while increasing investment in its growth initiatives and raising the full-year 2017 earnings per share projections. As per the first quarter results, the projected EPS ranges between $4.48 to $4.68 with a non GAAP earning ranging between $8.80 to $9.00. There was an increase in the companies next expense ratio due to the collapse of the Humana merger. In first-quarter 2017, Aetna experienced favorable development of prior years’ health care cost estimates in its Commercial, Medicaid and Medicare products, primarily attributable to fourth-quarter 2016 performance. 
